2CUREX — 2cureX AB Share News
0.000.00%
Last trade - 00:00- SEK47.95m
- SEK45.85m
Brief: 2Curex Gets Grant From German Federal Ministry Of Education And Research
Brief: 2Curex FY Loss Before Tax Widens To SEK 29.8 Mln
Brief: 2CureX Q3 Pre-Tax Loss Widens To SEK 8.4 Million
Brief: 2CureX Announces 2023 Goals
Brief: 2cureX Expands Cooperation With Werfen For Portuguese Market
Brief: 2Curex Expands Distribution Of Inditreat To Romania
Brief: 2CureX H1 Pre-Tax Loss Widens To SEK 14.3 Mln
Brief: 2cureX Expands Distribution Of Inditreat® To Israel
Brief: 2cureX Redefines Its Go-To-Market Strategy In North Europe
Brief: 2CureX Q1 Loss Before Tax Widens To SEK 7.9 Mln
Brief: 2Curex Q4 Pre-Tax Loss Widens To SEK 6.5 Mln
Brief: 2cureX Signs Agreement In Czech Republic And Slovakia
Brief: 2cureX's Inditreat To Be Distributed In Poland By Perlan Technologies
Brief: 2curex Receives Order From Distributor In Slovenia
Brief: 2cureX Signs Two Agreements With Diamedica Latvia, Lithuania
Brief: 2Curex Signs Distribution Agreement With Omnigen Medical Products In Turkey
Brief: 2CureX Provides Commercial Goals For 2022
Brief: 2Curex Signs Distribution Agreement With Labormed In Slovenia
Brief: 2Curex Signs Distribution Agreement With Werfen